Background: Spasticity is a very common neurological sequelae that significantly impacts
the quality of life of patients, affecting more than 12 million people worldwide. Botulinum …

Botulinum toxin type-A (BoNT-A) has emerged as a key therapeutic agent for the
management of spasticity. This paper presents a comprehensive bibliometric and visual …

Rehabilitation training is believed to be an effectual strategy that can reduce the risk of
dysfunction caused by spasticity. However, achieving visualization rehabilitation training for …

Introduction Spasticity, a prevalent manifestation of various neurological conditions,
significantly impacts the quality of life of patients. Research on the effects of oral drugs on …

Abstract Background The American Academy of Physical Medicine and Rehabilitation
(AAPM&R) conducted a comprehensive review in 2021 to identify opportunities for …

ABSTRACT Background Botulinum neurotoxin (BoNT) is frequently utilized for localized
spasticity in patients with spastic diplegic cerebral palsy (CP), while repetitive transcranial …

Spasticity is a disabling condition that frequently occurs after neurological injuries such as
stroke. Effective management of spasticity relies on the objective categorization for …

Spastic wrist flexion deformities both limit the functional use of the hand for grasp and pinch
producing a stigmatizing appearance. Tendon transfers and total wrist arthrodesis are …

Spasticity, a common neurological disorder with diverse etiologies, poses a complex
challenge for clinical management. Characterized as a velocity-dependent increase in …

iv Abstrakt Autor: Laura Pešková Vedoucí práce: Mgr. Irena Novotná Název: Kazuistika
fyzioterapeutické péče o pacienta s diagnózou amyotrofická laterální skleróza Cíle: Cílem …